Literature DB >> 99363

GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types.

Y Suzuki, N Nakamura, K Fukuoka.   

Abstract

Uptake of radioactivity from 14C-galactose into gangliosides by cultured skin fibroblasts was studied. GM3 was the major ganglioside in control human fibroblasts. An increase of GM1 was demonstrated in GM1-gangliosidosis fibroblasts. The degree of GM1 accumulation was correlated with the clinical types of this disease. The fibroblasts from an infantile-type patient showed a marked increase of GM1. In late-onset types the amount of total gangliosides was only slightly increased, but the distribution of individual gangliosides was definitely abnormal; a relative increase of GM1 was demonstrated in these cases. GM1 beta-galactosidase activities were not detectable in either infantile or late-onset cases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 99363     DOI: 10.1007/bf00293589

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

1.  Gangliosides of chemically and virally transformed rat embryo cells.

Authors:  R Langenbach
Journal:  Biochim Biophys Acta       Date:  1975-05-22

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy.

Authors:  M T Porter; A L Fluharty; J Trammell; H Kihara
Journal:  Biochem Biophys Res Commun       Date:  1971-08-06       Impact factor: 3.575

4.  Gangliosides of cultured mouse cells. Partial characterization and demonstration of 14C-glucosamine incorporation.

Authors:  G Yogeeswaran; J R Wherrett; S Chatterjee; R K Murray
Journal:  J Biol Chem       Date:  1970-12-25       Impact factor: 5.157

5.  Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts.

Authors:  M Cantz; J Gehler; J Spranger
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

6.  The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservation.

Authors:  K Suzuki
Journal:  J Neurochem       Date:  1965-07       Impact factor: 5.372

7.  beta-Galactosidase deficiency in juvenile and adult patients. Report of six Japanese cases and review of literature.

Authors:  Y Suzuki; N Nakamura; K Fukuoka; Y Shimada; M Uono
Journal:  Hum Genet       Date:  1977-04-15       Impact factor: 4.132

8.  beta-Galactosidase in mucopolysaccharidoses and mucolipidoses. Deficiency of GM1 beta-galactosidase in liver and leukocytes.

Authors:  Y Suzuki; K Fukuoka; J J Wey; S Handa
Journal:  Clin Chim Acta       Date:  1977-02-15       Impact factor: 3.786

9.  Generalized gangliosidosis: beta-galactosidase deficiency.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1968-05-31       Impact factor: 47.728

10.  Increased levels of sialic acid associated with a sialidase deficiency in I-cell disease (mucolipidosis II) fibroblasts.

Authors:  G H Thomas; G E Tiller; L W Reynolds; C S Miller; J W Bace
Journal:  Biochem Biophys Res Commun       Date:  1976-07-12       Impact factor: 3.575

View more
  8 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 2.  The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis.

Authors:  Frederick M Lang; Paul Korner; Mark Harnett; Ajith Karunakara; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2019-12-30       Impact factor: 4.797

3.  GM1-Gangliosidosis: a molecular abnormality of acid beta-galactosidase in fibroblasts.

Authors:  T Furuya; Y Suzuki
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

4.  Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases.

Authors:  K Yoshida; A Oshima; M Shimmoto; Y Fukuhara; H Sakuraba; N Yanagisawa; Y Suzuki
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

Review 5.  Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration.

Authors:  L D Osellame; M R Duchen
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

6.  Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.

Authors:  Yoshiyuki Suzuki; Seiichiro Ogawa; Yasubumi Sakakibara
Journal:  Perspect Medicin Chem       Date:  2009-05-26

7.  In cellulo examination of a beta-alpha hybrid construct of beta-hexosaminidase A subunits, reported to interact with the GM2 activator protein and hydrolyze GM2 ganglioside.

Authors:  Incilay Sinici; Sayuri Yonekawa; Ilona Tkachyova; Steven J Gray; R Jude Samulski; Warren Wakarchuk; Brian L Mark; Don J Mahuran
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

8.  Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience.

Authors:  Rita Fischetto; Valentina Palladino; Maria M Mancardi; Thea Giacomini; Stefano Palladino; Alberto Gaeta; Maja Di Rocco; Lucia Zampini; Giuseppe Lassandro; Vito Favia; Maria E Tripaldi; Pietro Strisciuglio; Alfonso Romano; Mariasavina Severino; Amelia Morrone; Paola Giordano
Journal:  Mol Genet Genomic Med       Date:  2020-08-11       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.